Marie Thibault
Stock Analyst at BTIG
(1.57)
# 930
Out of 4,667 analysts
73
Total ratings
66.67%
Success rate
9.51%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $260 → $270 | $266.58 | +1.28% | 4 | Nov 8, 2024 | |
| MASI Masimo | Maintains: Buy | $166 → $170 | $164.95 | +3.06% | 3 | Oct 14, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $62 → $65 | $41.81 | +55.47% | 8 | Oct 14, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $84 → $93 | $90.17 | +3.14% | 7 | Oct 14, 2024 | |
| HAE Haemonetics | Initiates: Buy | $112 | $84.92 | +31.89% | 1 | Sep 10, 2024 | |
| ATRC AtriCure | Maintains: Buy | $58 → $53 | $36.03 | +47.10% | 4 | Jul 31, 2024 | |
| DXCM DexCom | Maintains: Buy | $156 → $120 | $75.24 | +59.49% | 7 | Jul 26, 2024 | |
| XAIR Beyond Air | Downgrades: Neutral | n/a | $0.49 | - | 2 | Jun 25, 2024 | |
| VERO Venus Concept | Downgrades: Neutral | n/a | $0.30 | - | 3 | Oct 6, 2023 | |
| DCTH Delcath Systems | Maintains: Buy | $19 → $20 | $9.63 | +107.68% | 3 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $140 | $73.74 | +89.86% | 7 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.55 | +94.17% | 3 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $125 | $115.93 | +7.82% | 11 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $97 | $49.00 | +97.96% | 3 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $13.61 | - | 1 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $7 | $1.83 | +282.51% | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.80 | - | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.32 | - | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $208.67 | -97.12% | 1 | Apr 9, 2020 |
Insulet
Nov 8, 2024
Maintains: Buy
Price Target: $260 → $270
Current: $266.58
Upside: +1.28%
Masimo
Oct 14, 2024
Maintains: Buy
Price Target: $166 → $170
Current: $164.95
Upside: +3.06%
Establishment Labs Holdings
Oct 14, 2024
Maintains: Buy
Price Target: $62 → $65
Current: $41.81
Upside: +55.47%
Boston Scientific
Oct 14, 2024
Maintains: Buy
Price Target: $84 → $93
Current: $90.17
Upside: +3.14%
Haemonetics
Sep 10, 2024
Initiates: Buy
Price Target: $112
Current: $84.92
Upside: +31.89%
AtriCure
Jul 31, 2024
Maintains: Buy
Price Target: $58 → $53
Current: $36.03
Upside: +47.10%
DexCom
Jul 26, 2024
Maintains: Buy
Price Target: $156 → $120
Current: $75.24
Upside: +59.49%
Beyond Air
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.49
Upside: -
Venus Concept
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.30
Upside: -
Delcath Systems
Aug 16, 2023
Maintains: Buy
Price Target: $19 → $20
Current: $9.63
Upside: +107.68%
Jun 8, 2023
Maintains: Buy
Price Target: $165 → $140
Current: $73.74
Upside: +89.86%
Mar 29, 2023
Maintains: Buy
Price Target: $4 → $3
Current: $1.55
Upside: +94.17%
Jan 26, 2023
Maintains: Buy
Price Target: $120 → $125
Current: $115.93
Upside: +7.82%
Oct 17, 2022
Maintains: Buy
Price Target: $100 → $97
Current: $49.00
Upside: +97.96%
Sep 8, 2022
Initiates: Neutral
Price Target: n/a
Current: $13.61
Upside: -
Jun 24, 2022
Maintains: Buy
Price Target: $9 → $7
Current: $1.83
Upside: +282.51%
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.80
Upside: -
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.32
Upside: -
Apr 9, 2020
Maintains: Buy
Price Target: $11 → $6
Current: $208.67
Upside: -97.12%